Compare · CELC vs ELV
CELC vs ELV
Side-by-side comparison of Celcuity Inc. (CELC) and Elevance Health Inc. (ELV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CELC and ELV operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $92.84B, about 31.7x CELC ($2.93B).
- Over the past year, CELC is up 4.7% and ELV is up 23.1% - ELV leads by 18.4 points.
- CELC has been more active in the news (8 items in the past 4 weeks vs 3 for ELV).
- ELV has more recent analyst coverage (23 ratings vs 15 for CELC).
- Company
- Celcuity Inc.
- Elevance Health Inc.
- Price
- $55.11-8.58%
- $428.76+0.08%
- Market cap
- $2.93B
- $92.84B
- 1M return
- -35.16%
- +3.39%
- 1Y return
- +4.70%
- +23.07%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2017
- News (4w)
- 8
- 3
- Recent ratings
- 15
- 23
Celcuity Inc.
Celcuity Inc., a clinical stage biotechnology company, discovers cancer sub-types and therapeutic options for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest CELC
- SEC Form 4 filed by Celcuity Inc.
- SEC Form 4 filed by Celcuity Inc.
- SEC Form 3 filed by Celcuity Inc.
- Celcuity Announces Multiple Presentations At The European Society For Medical Oncology (ESMO) Congress 2026
- Celcuity Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Celcuity Appoints David Gryska To Its Board Of Directors
- Celcuity Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Celcuity Announces That REVTORPYK™ (gedatolisib) Is Now Commercially Available In The United States
- Analyst initiated coverage on Celcuity with a new price target
- Celcuity To Participate in Upcoming Investor Conferences
Latest ELV
- SEC Form 4 filed by Elevance Health Inc.
- Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2026 Results on October 21, 2026
- Elevance Health’s Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated Support
- Elevance Health Inc. filed SEC Form 8-K: Regulation FD Disclosure
- EVP & Chief Legal Officer Wessling Erin M covered exercise/tax liability with 349 shares, decreasing direct ownership by 5% to 7,230 units (SEC Form 4)
- EVP & Chief HR Officer Craig Ryan R covered exercise/tax liability with 144 shares, decreasing direct ownership by 2% to 6,530 units (SEC Form 4)
- Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey
- Director Peru Ramiro G bought $366,050 worth of shares (1,000 units at $366.05), increasing direct ownership by 10% to 10,908 units (SEC Form 4)
- President and CEO Boudreaux Gail bought $1,002,230 worth of shares (2,725 units at $367.79), increasing direct ownership by 2% to 171,976 units (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.